Position in RLAY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,958,245
+$6,293,000 QoQ
Shares Held
692,584
+3.4% QoQ
Ownership
0.316%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 256 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. RLAY ranks #50 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in RLAY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,958,245 | 692,584 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,665,245 | 669,874 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $7,321,967 | 865,481 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,885,410 | 361,190 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $945,902 | 273,383 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $484,255 | 184,831 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $491,996 | 119,417 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $808,222 | 114,156 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $746,624 | 114,513 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $970,128 | 116,883 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,619,361 | 147,081 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,289,319 | 153,308 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,593,662 | 126,884 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,218,005 | 73,953 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $879,486 | 58,868 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,293,142 | 57,807 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $965,117 | 57,619 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,596,046 | 53,326 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $916,232 | 29,835 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $863,763 | 27,395 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $851,704 | 23,277 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $330,211 | 9,552 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $291,085 | 7,004 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||